Waters Corporation Capital expenditures

Capital expenditures of WAT for past 10 years: annual, quarterly and twelve month trailing (TTM) including Capital expenditures growth rates and interactive chart. Capital expenditures, commonly known as Capex, are funds used by a company to acquire, upgrade, and maintain physical or intangible assets such as property, buildings, an industrial plant, technology, software or equipment. Capex is often used to undertake new projects or investments by the firm. A company must invest over its lifetime into productive assets to maintain its competitiveness and ensure its survival.

Highlights and Quick Summary

  • Capital expenditures for the quarter ending December 30, 2020 was $-47 Million (a 66.17% increase compared to previous quarter)
  • Year-over-year quarterly Capital expenditures decreased by -7.99%
  • Annual Capital expenditures for 2020 was $-172 Million (a 5.23% increase from previous year)
  • Annual Capital expenditures for 2019 was $-164 Million (a 70.51% increase from previous year)
  • Annual Capital expenditures for 2018 was $-96.1 Million (a 12.41% increase from previous year)
  • Twelve month Capital expenditures ending December 30, 2020 was $-172 Million (a -3.67% decrease compared to previous quarter)
  • Twelve month trailing Capital expenditures decreased by -8.93% year-over-year
Trailing Capital expenditures for the last four month:
30 Dec '20 29 Sep '20 29 Jun '20 30 Mar '20
$-172 Million $-179 Million $-196 Million $-189 Million
Visit stockrow.com/WAT for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Capital expenditures of Waters Corporation

Most recent Capital expendituresof WAT including historical data for past 10 years.

Interactive Chart of Capital expenditures of Waters Corporation

Waters Corporation Capital expenditures for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $-47.04 $-28.31 $-45.9 $-51.13 $-172.38
2019 $-53.62 $-45.02 $-39.52 $-25.67 $-163.82
2018 $-0.38 $-58.87 $-20.84 $-15.99 $-96.08
2017 $-30.22 $-19.9 $-17.65 $-17.71 $-85.47
2016 $-22.67 $-18.6 $-25.04 $-24.65 $-90.97
2015 $-27.76 $-21.8 $-23.88 $-21.41 $-94.86
2014 $-19.12 $-26.29 $-22.76 $-21.4 $-89.56
2013 $-25.63 $-31.54 $-30.64 $-30.64 $-118.45
2012 $-31.7 $-26.13 $-31.39 $-15.53 $-104.75
2011 $-34.09 $-16.07 $-18.43 $-16.84 $-85.44
2010 $-15.46 $-26.05 $-11.06 $-62.74

Business Profile of Waters Corporation

Sector: Healthcare
Industry: Diagnostics & Research
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company has a collaboration with Genovis AB to develop and market biopharmaceutical characterization workflows based on the its BioAccord LC-MS System, Andrew+ pipetting robot and Genovis SmartEnzymes. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.